The authors conclude that use of GLP-1 agonists probably has little or no effect on risk of breast cancer, kidney cancer, pancreatic cancer, or thyroid cancer ( moderate certainty )
Presenters in the two-hour webinar and question/answer session included several physicians from the Centers of Disease Control and Prevention, Imperial College London, Cohen Childrens Medical Center and Emory University School of Medicine
By taking proactive steps, you can minimize the risk and support stronger, healthier hair throughout your weight loss journey
Every case is unique, and treatment must be aligned with the patients diagnosis, age, and overall health status
Whether your goal is appetite regulation, blood sugar balance, reduced cravings, or simply seeing how your body responds to GIP/GLP-1 activation before committing to higher doses, every plan begins with a thorough medical evaluation tailored to your unique physiology